Literature DB >> 22475261

Mucin biopolymers as broad-spectrum antiviral agents.

Oliver Lieleg1, Corinna Lieleg, Jesse Bloom, Christopher B Buck, Katharina Ribbeck.   

Abstract

Mucus is a porous biopolymer matrix that coats all wet epithelia in the human body and serves as the first line of defense against many pathogenic bacteria and viruses. However, under certain conditions viruses are able to penetrate this infection barrier, which compromises the protective function of native mucus. Here, we find that isolated porcine gastric mucin polymers, key structural components of native mucus, can protect an underlying cell layer from infection by small viruses such as human papillomavirus (HPV), Merkel cell polyomavirus (MCV), or a strain of influenza A virus. Single particle analysis of virus mobility inside the mucin barrier reveals that this shielding effect is in part based on a retardation of virus diffusion inside the biopolymer matrix. Our findings suggest that purified mucins may be used as a broad-range antiviral supplement to personal hygiene products, baby formula or lubricants to support our immune system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475261      PMCID: PMC3597216          DOI: 10.1021/bm3001292

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  46 in total

1.  The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor.

Authors:  J N Varghese; J L McKimm-Breschkin; J B Caldwell; A A Kortt; P M Colman
Journal:  Proteins       Date:  1992-11

2.  Porcine gastric mucin binds to recombinant norovirus particles and competitively inhibits their binding to histo-blood group antigens and Caco-2 cells.

Authors:  P Tian; M Brandl; R Mandrell
Journal:  Lett Appl Microbiol       Date:  2005       Impact factor: 2.858

3.  Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces.

Authors:  Hirotoshi Matsui; Margrith W Verghese; Mehmet Kesimer; Ute E Schwab; Scott H Randell; John K Sheehan; Barbara R Grubb; Richard C Boucher
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

4.  Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.

Authors:  Jesse D Bloom; Lizhi Ian Gong; David Baltimore
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

5.  Early stages of influenza virus entry into Mv-1 lung cells: involvement of dynamin.

Authors:  A M Roy; J S Parker; C R Parrish; G R Whittaker
Journal:  Virology       Date:  2000-02-01       Impact factor: 3.616

6.  Interaction of HIV-1 and human salivary mucins.

Authors:  E J Bergey; M I Cho; B M Blumberg; M L Hammarskjöld; D Rekosh; L G Epstein; M J Levine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-10

7.  Rheology of gastric mucin exhibits a pH-dependent sol-gel transition.

Authors:  Jonathan P Celli; Bradley S Turner; Nezam H Afdhal; Randy H Ewoldt; Gareth H McKinley; Rama Bansil; Shyamsunder Erramilli
Journal:  Biomacromolecules       Date:  2007-04-03       Impact factor: 6.988

8.  Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus.

Authors:  Yen Cu; W Mark Saltzman
Journal:  Mol Pharm       Date:  2009 Jan-Feb       Impact factor: 4.939

9.  Quantitation of human seroresponsiveness to Merkel cell polyomavirus.

Authors:  Diana V Pastrana; Yanis L Tolstov; Jürgen C Becker; Patrick S Moore; Yuan Chang; Christopher B Buck
Journal:  PLoS Pathog       Date:  2009-09-11       Impact factor: 6.823

10.  The role of crude human saliva and purified salivary MUC5B and MUC7 mucins in the inhibition of Human Immunodeficiency Virus type 1 in an inhibition assay.

Authors:  Habtom H Habte; Anwar S Mall; Corena de Beer; Zoë E Lotz; Delawir Kahn
Journal:  Virol J       Date:  2006-11-24       Impact factor: 4.099

View more
  37 in total

1.  Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.

Authors:  Andrew J Burnham; Tatiana Baranovich; Bindumadhav M Marathe; Jianling Armstrong; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

2.  Predicting first traversal times for virions and nanoparticles in mucus with slowed diffusion.

Authors:  Austen M Erickson; Bruce I Henry; John M Murray; Per Johan Klasse; Christopher N Angstmann
Journal:  Biophys J       Date:  2015-07-07       Impact factor: 4.033

3.  Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors.

Authors:  Benjamin S Schuster; Anthony J Kim; Joshua C Kays; Mia M Kanzawa; William B Guggino; Michael P Boyle; Steven M Rowe; Nicholas Muzyczka; Jung Soo Suk; Justin Hanes
Journal:  Mol Ther       Date:  2014-05-29       Impact factor: 11.454

4.  Mucin biopolymers prevent bacterial aggregation by retaining cells in the free-swimming state.

Authors:  Marina Caldara; Ronn S Friedlander; Nicole L Kavanaugh; Joanna Aizenberg; Kevin R Foster; Katharina Ribbeck
Journal:  Curr Biol       Date:  2012-11-08       Impact factor: 10.834

5.  Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus.

Authors:  Corleone S Delaveris; Elizabeth R Webster; Steven M Banik; Steven G Boxer; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-26       Impact factor: 11.205

6.  Core 2 Mucin-Type O-Glycan Is Related to EPEC and EHEC O157:H7 Adherence to Human Colon Carcinoma HT-29 Epithelial Cells.

Authors:  Jun Ye; Lili Song; Yun Liu; Qiong Pan; Xiaoli Zhong; Shanshan Li; Yangyang Shang; Yin Tian; Yonghong He; Lei Chen; Wensheng Chen; Zhihong Peng; Rongquan Wang
Journal:  Dig Dis Sci       Date:  2015-02-21       Impact factor: 3.199

Review 7.  Glycomaterials for probing host-pathogen interactions and the immune response.

Authors:  Mia L Huang; Christopher J Fisher; Kamil Godula
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

8.  Theaflavin-3,3'-digallate and lactic acid combinations reduce herpes simplex virus infectivity.

Authors:  Charles E Isaacs; Weimin Xu
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

9.  Enhanced membrane-tethered mucin 3 (MUC3) expression by a tetrameric branched peptide with a conserved TFLK motif inhibits bacteria adherence.

Authors:  Qiong Pan; Yin Tian; Xiaohuan Li; Jun Ye; Yun Liu; Lili Song; Yongtao Yang; Rong Zhu; Yonghong He; Lei Chen; Wensheng Chen; Xuhu Mao; Zhihong Peng; Rongquan Wang
Journal:  J Biol Chem       Date:  2013-01-10       Impact factor: 5.157

10.  Mucus blocks probiotics but increases penetration of motile pathogens and induces TNF-α and IL-8 secretion.

Authors:  Abhinav Sharma; Vishnu Raman; Jungwoo Lee; Neil S Forbes
Journal:  Biotechnol Bioeng       Date:  2020-06-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.